Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you consider eliminating post lumpectomy RT in a premenopausal patient with pCR after chemotherapy for a cT1cN0 triple negative breast cancer?
Answer from: Radiation Oncologist at Community Practice
We don't have any prospective data on omitting RT in this case and would not consider this approach for triple negative patients.
Sign In
or
Register
to read more
12900
Related Questions
Does a high genomic risk score impact your radiation fields for patients with breast cancer?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
Does the presence of LCIS on pathology in a patient with IDC impact your decision to offer APBI?
Would you consider 5-fraction whole breast RT for a patient with multiple positive margins following lumpectomy for whom reexcision is not possible?
When do you start adjuvant radiation with areas of delayed wound healing after reduction mammoplasty?
Do you recommend high ozonated oil for radiation dermatitis?
In a young woman with large invasive breast carcinoma (case: pT3, lobular) s/p skin sparing mastectomy with positive anterior margin, what is the practical role for re-excision with or without PMRT?
Would you offer ultra-hypofractionated accelerated partial breast re-irradiation using 5 fractions?
In what patients is it inappropriate to offer DCISionRT testing?
Would you recommend PMRT in a patient with a triple negative cT2N0, ypT2N0 metaplastic breast cancer s/p NAC, mastectomy, and SLNB?